Phase I Trial of a Bivalent Gangliosides Vaccine in Combination With -Glucan for High-Risk Neuroblastoma in Second or Later Remission

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-1012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Phase I Study of Selinexor in Combination With High-Dose Cytarabine and Mitoxantrone for Remission Induction in Patients With Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Dinutuximab Combination Therapy Becomes First Approval for High-Risk Neuroblastoma

Journal of Community and Supportive Oncology
OncologyHematology
2015English

Phase I Trial of SAR103168, a Novel Multi-Kinase Inhibitor, in Patients With Refractory/Relapsed Acute Leukemia or High-Risk Myelodysplastic Syndrome

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2014English

Phase I Trial of Sorafenib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Phase I Trial of Sorafenib in Combination With Gefitinib in Patients With Refractory or Recurrent Non Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2007English

Autologous Hematopoietic Cell Transplantation Can Prolong Life in High-Risk Neuroblastoma Patients in Partial Remission

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer

Investigational New Drugs
OncologyPharmacology
2014English

Glasdegib in Combination With Cytarabine and Daunorubicin in Patients With AML or High-Risk MDS: Phase 2 Study Results

American Journal of Hematology
Hematology
2018English

A First-In-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination With Erlotinib in Advanced Cancer

Clinical Cancer Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy